| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |